Frederick T. Sullivan Purchases 124,933 Shares of Senseonics Holdings, Inc. (NYSE:SENS) Stock

Senseonics Holdings, Inc. (NYSE:SENS) CFO Frederick T. Sullivan acquired 124,933 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The shares were bought at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the acquisition, the chief financial officer now directly owns 2,478,844 shares in the company, valued at $941,960.72. This represents a 5.31 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Senseonics Stock Performance

NYSE:SENS opened at $0.46 on Friday. The stock has a market cap of $273.20 million, a P/E ratio of -3.53 and a beta of 0.77. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. Senseonics Holdings, Inc. has a twelve month low of $0.25 and a twelve month high of $0.75. The business’s 50-day moving average price is $0.33 and its two-hundred day moving average price is $0.38.

Analyst Ratings Changes

SENS has been the topic of several recent analyst reports. HC Wainwright reaffirmed a “buy” rating and issued a $2.00 price target on shares of Senseonics in a report on Friday, November 15th. StockNews.com initiated coverage on Senseonics in a report on Tuesday. They issued a “sell” rating on the stock.

Hedge Funds Weigh In On Senseonics

A number of large investors have recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Senseonics by 0.7% during the 1st quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock valued at $11,963,000 after buying an additional 155,715 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Senseonics by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock valued at $2,042,000 after buying an additional 179,103 shares in the last quarter. Symmetry Partners LLC purchased a new position in shares of Senseonics during the 3rd quarter valued at about $164,000. Cubist Systematic Strategies LLC raised its holdings in shares of Senseonics by 25.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after buying an additional 85,501 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its holdings in shares of Senseonics by 16.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock valued at $196,000 after buying an additional 51,000 shares in the last quarter. 12.36% of the stock is owned by hedge funds and other institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.